Statins and hepatotoxicity: Focus on patients with fatty liver

被引：205
作者：
Chalasani, N [1 ]
机构：
[1] Indiana Univ, Sch Med, Indianapolis, IN 46202 USA
来源：
HEPATOLOGY | 2005年 / 41卷 / 04期
关键词：
D O I：
10.1002/hep.20671
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：690 / 695
页数：6
相关论文
共 49 条
[41]   Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S) [J].
Strandberg, TE ;
Pyörälä, K ;
Cook, TJ ;
Wilhelmsen, L ;
Faergeman, O ;
Thorgeirsson, G ;
Pedersen, TR ;
Kjekshus, J .
LANCET, 2004, 364 (9436) :771-777
[42]  
*THOMPS HEALTHC, 2005, PHYS DESK REF 2005
[43]   Statin-associated myopathy [J].
Thompson, PD ;
Clarkson, P ;
Karas, RH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (13) :1681-1690
[44]   The liver and lovastatin [J].
Tolman, KG .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (12) :1374-1380
[45]  
Tolman KG, 2000, AM J CARDIOL, V85, p15E
[46]  
VESSEY D, 2003, HEPATOLOGY TXB LIVER, P185
[47]   Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes [J].
Vuppalanchi, RAJ ;
Teal, E ;
Chalasani, N .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2005, 329 (02) :62-65
[48]   Hepatic cytochrome p450 2E1 is increased in patients with nonalcoholic steatohepatitis [J].
Weltman, MD ;
Farrell, GC ;
Hall, P ;
Ingelman-Sundberg, M ;
Liddle, C .
HEPATOLOGY, 1998, 27 (01) :128-133
[49]  
*WWW DRUGTOPICS CO, PHARM FACTS FIG
12345